Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 696

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 696
---
     | Cost ($000’) |
| Abecma   |     | Multiple Myeloma             |     | Celegene              |     |        419.5 |
| Breyanzi |     | Large B-Cell Lymphoma        |     | Juno Therapeutics     |     |        410.3 |
| Carvykti |     | Multiple Myeloma             |     | Janssen Biotech       |     |        465.0 |
| Kymriah  |     | Follicular Lymphoma          |     | Novartis              |     |        475.0 |
| Lantidra |     | Type 1 Diabetes              |     | CellTrans             |     |        300.0 |
| Maci     |     | Knee/Joint defects           |     | Vericel               |     |         40.0 |
| Omisirge |     | Blood Cancers                |     | Gamida cells          |     |        338.0 |
| Provenge |     | Prostste cancer              |     | Dendreon              |     |         93.0 |
| Rethymic |     | Congenital Athymia           |     | Enzyvant Therapeutics |     |      2,700.0 |
| Tecartus |     | Acute Lymphoblastic Leukemia |     | Kite Pharma           |     |        373.0 |
| Yescarta |     | Large B-Cell Lymphoma        |     | Kite Pharma           |     |        373.0 |

____________ 4Gene and Cell Therapies: Navigating the Challenges Around Rising Costs in Medical Insurance ( https://www.guycarp.com/ )

| Moore Financial Consulting |

Annex E-18

Methodology Methodology for asset valuation A valuation of business, operations, assets or liabilities can be carried out according to one or more methodologies for valuation. For the most part, the general practice divides the valuation methodologies between the three following main approaches: •The Cost Approach/Net Asset Value (NAV). •The Comparative Method/Market Approach. •The Income/Earnings Approach Valuation methodology can make use of one or more of the approaches above. Choosing the appropriate valuation methodology varies from case to case. While each of the various approaches and methodologies has its own uniqueness and is suitable for other types of assets or evaluating various business situations. In addition, all